URINE EXOSOME mRNAs AND METHODS OF USING SAME TO DETECT DIABETIC NEPHROPATHY
US-2016222456-A1 · Aug 4, 2016 · US
US9719129B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9719129-B2 |
| Application number | US-201114122920-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 10, 2011 |
| Priority date | Jun 10, 2011 |
| Publication date | Aug 1, 2017 |
| Grant date | Aug 1, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a device that collects vesicles and vesicle-like materials from biological fluids. Such devices comprise at least one sample loading region; at least one corresponding vesicle-capture material, wherein said vesicle-capture material comprises glass-like materials; and at least one corresponding sample receiving region, wherein passage of the biological fluid from the sample loading region through the vesicle capture material and into the sample receiving region results in the capture of vesicles. Additional methods provide for a method of isolating vesicles and vesicle-like materials from biological fluids are also provided.
Opening claim text (preview).
What is claimed is: 1. A method of isolating vesicles from biological fluid, comprising: (a) obtaining a biological fluid sample comprising vesicles having a diameter of less than 0.5 micrometers; (b) loading at least a portion of said biological fluid sample into a sample loading region of a vesicle capture device, said portion of said biological fluid sample comprising blood plasma and vesicles having a diameter of less than 0.5 micrometers; (c) passing said portion of said biological fluid sample from said sample loading region through a vesicle-capture material in said vesicle capture device, said vesicle-capture material comprising at least a first layer and a second layer, both of glassfiber, at least a portion of said vesicles having a diameter of less than 0.5 micrometers adsorbing to and being retained by the vesicle-capture material, thereby producing a supernatant, wherein said first layer is closer to said sample loading region than said second layer, wherein said first layer has a porosity configured to capture material that is 1.6 micrometers or greater in diameter, wherein said second layer has a porosity configured to capture material that is 0.6 micrometers to 0.8 micrometers or greater in diameter; and (d) passing said supernatant to a sample receiving region of said vesicle capture device, thereby isolating vesicles from the biological fluid sample. 2. The method of claim 1 , wherein said vesicle-capture material further comprises a non glass-like material. 3. The method of claim 2 , wherein said non glass-like material comprises nitrocellulose. 4. The method of claim 1 , wherein said passings are accomplished through the application of vacuum pressure to the device. 5. The method of claim 1 , wherein said passings are accomplished through the application of positive pressure to the device. 6. The method of claim 1 , wherein said passings are accomplished through low-speed centrifugation of the device. 7. The method of claim 1 , wherein said vesicle capture device is configured in a multi-well plate format. 8. The method of claim 1 , further comprising eluting said vesicles from said vesicle-capture material. 9. A method of isolating vesicle-associated RNA from a biological fluid comprising vesicles, the method comprising: (a) obtaining a biological fluid sample comprising blood plasma and vesicles having a diameter of less than 0.5 micrometers; (b) loading said biological fluid sample into a sample loading region of a vesicle capture device; (c) passing said biological fluid sample from said sample loading region through a vesicle-capture material in said vesicle capture device, said vesicle-capture material comprising at least a first layer and a second layer, both of glassfiber, thereby producing a supernatant, wherein said first layer has a porosity configured to capture particles that are 1.6 micrometers or greater in diameter, and wherein said second layer has a porosity configured to capture particles that are 0.6 micrometers to 0.8 micrometers or greater in diameter; (d) passing said supernatant to a sample receiving region of said vesicle capture device and discarding the supernatant, wherein said passings result in capture of at least a portion of said vesicles having a diameter of less than 0.5 micrometers from said biological fluid sample on or in said vesicle-capture material; (e) lysing said vesicle on or in said vesicle-capture material to create a lysate; and (f) collecting the lysate from both of said first and second layers of said vesicle-capture material into a single receiving region, thereby isolating vesicle-associated RNA from the biological fluid sample comprising vesicles.
the material being filamentary or fibrous · CPC title
Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.